Danske Bank’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.24K Sell
100
-1,100
-92% -$110K ﹤0.01% 819
2025
Q4
$123K Buy
1,200
+200
+20% +$17.9K ﹤0.01% 738
2025
Q3
$62.5K Hold
1,000
﹤0.01% 959
2025
Q2
$52K Buy
+1,000
New +$44.7K ﹤0.01% 1018
2024
Q4
Sell
-4,400
Closed -$101K 1496
2024
Q3
$101K Buy
+4,400
New +$125K ﹤0.01% 1014

Other funds holding GH

Danske Bank's GH Position: Q1 2026 in Review

Danske Bank reduced its Guardant Health (GH) stake by 92% in Q1 2026, selling an estimated $110K and leaving 100 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Danske Bank first reported a position in GH in Q3 2024 and has held it in 5 quarters since. The position peaked at $123K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Danske Bank held 100 shares of Guardant Health worth $9.24K as of Q1 2026.
  • Danske Bank sold 1,100 Guardant Health shares in Q1 2026, an estimated $110K.
  • Guardant Health made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #819 holding.
  • Danske Bank first reported a position in Guardant Health in Q3 2024 and has held it in 5 quarters since.
  • Danske Bank's Guardant Health position peaked at $123K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.